Abstract:Purpose Articular chondroprogenitors, a suitable contender for cell-based therapy in cartilage repair, routinely employ fetal bovine serum (FBS) for expansion and differentiation. The possibility of transplant rejections or zoonoses transmissions raise a need for xeno-free alternatives. Use of human platelet lysate (hPL), a nutrient supplement abundant in growth factors, has not been reported for human chondroprogenitor expansion thus far. Our aim was to compare the biological profile of chondroprogenitors gro… Show more
“…14 Supplementation with platelet lysate as opposed to FBS caused chondroprogenitors to show comparatively higher alizarin red uptake. 17 Commonly reported positive MSC markers included CD105 (n = 17), CD90 (n = 20), CD73 (n = 12), while negative MSC markers included CD34 (n = 15) and CD45 (n = 15). Numerous reports evaluated the following cell surface proteins as potential markers of chondrogenesis namely CD29 (n = 12) in combination with CD49e (n = 19), CD146 (n = 4), and CD166 (n = 13).…”
Section: Table 1 (Continued)mentioning
confidence: 95%
“…14 It was also seen that for creation of xeno-free culture conditions, when human platelet lysate was used in place of FBS, progenitors displayed greater proliferation with lower expression of type I and X collagen (fibrocartilage and hypertrophy markers). 17 With regard to culture conditions producing maximum growth of progenitors, Melero et al report an optimal seeding density of 10,000 cells/cm 2 and medium volume of 0.3 mL/cm 2 . 18,19 The authors further demonstrated an efficient post-cryoviability and 17-fold expansion potential using macroporous microcarrier supplemented with 40% FCS and 1 ng/mL of TGFβ1.…”
Objective Chondroprogenitors have recently gained prominence due to promising results seen in in vitro and animal studies as a potential contender in cell-based therapy for cartilage repair. Lack of consensus regarding nomenclature, isolation techniques, and expansion protocols create substantial limitations for translational research, especially given the absence of distinct markers of identification. The objective of this systematic review was to identify and collate information pertaining to hyaline cartilage–derived chondroprogenitors, with regard to their isolation, culture, and outcome measures. Design As per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a web-based search of Scopus and PubMed databases was performed from January 2000 to May 2020, which yielded 509 studies. A total of 65 studies were identified that met the standardized inclusion criteria which comprised of, but was not limited to, progenitors derived from fibronectin adhesion, migrated subpopulation from explant cultures, and single-cell sorting. Result Literature search revealed that progenitors demonstrated inherent chondrogenesis and minimal tendency for hypertrophy. Multiple sources also demonstrated significantly better outcomes that bone marrow–derived mesenchymal stem cells and comparable results to chondrocytes. With regard to progenitor subgroups, collated evidence points to better and consistent outcomes with the use of migratory progenitors when compared to fibronectin adhesion assay–derived progenitors, although a direct comparison between the two cell populations is warranted. Conclusion Since chondroprogenitors exhibit favorable properties for cartilage repair, efficient characterization of progenitors is imperative, to complete their phenotypic profile, so as to optimize their use in translational research for neocartilage formation.
“…14 Supplementation with platelet lysate as opposed to FBS caused chondroprogenitors to show comparatively higher alizarin red uptake. 17 Commonly reported positive MSC markers included CD105 (n = 17), CD90 (n = 20), CD73 (n = 12), while negative MSC markers included CD34 (n = 15) and CD45 (n = 15). Numerous reports evaluated the following cell surface proteins as potential markers of chondrogenesis namely CD29 (n = 12) in combination with CD49e (n = 19), CD146 (n = 4), and CD166 (n = 13).…”
Section: Table 1 (Continued)mentioning
confidence: 95%
“…14 It was also seen that for creation of xeno-free culture conditions, when human platelet lysate was used in place of FBS, progenitors displayed greater proliferation with lower expression of type I and X collagen (fibrocartilage and hypertrophy markers). 17 With regard to culture conditions producing maximum growth of progenitors, Melero et al report an optimal seeding density of 10,000 cells/cm 2 and medium volume of 0.3 mL/cm 2 . 18,19 The authors further demonstrated an efficient post-cryoviability and 17-fold expansion potential using macroporous microcarrier supplemented with 40% FCS and 1 ng/mL of TGFβ1.…”
Objective Chondroprogenitors have recently gained prominence due to promising results seen in in vitro and animal studies as a potential contender in cell-based therapy for cartilage repair. Lack of consensus regarding nomenclature, isolation techniques, and expansion protocols create substantial limitations for translational research, especially given the absence of distinct markers of identification. The objective of this systematic review was to identify and collate information pertaining to hyaline cartilage–derived chondroprogenitors, with regard to their isolation, culture, and outcome measures. Design As per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a web-based search of Scopus and PubMed databases was performed from January 2000 to May 2020, which yielded 509 studies. A total of 65 studies were identified that met the standardized inclusion criteria which comprised of, but was not limited to, progenitors derived from fibronectin adhesion, migrated subpopulation from explant cultures, and single-cell sorting. Result Literature search revealed that progenitors demonstrated inherent chondrogenesis and minimal tendency for hypertrophy. Multiple sources also demonstrated significantly better outcomes that bone marrow–derived mesenchymal stem cells and comparable results to chondrocytes. With regard to progenitor subgroups, collated evidence points to better and consistent outcomes with the use of migratory progenitors when compared to fibronectin adhesion assay–derived progenitors, although a direct comparison between the two cell populations is warranted. Conclusion Since chondroprogenitors exhibit favorable properties for cartilage repair, efficient characterization of progenitors is imperative, to complete their phenotypic profile, so as to optimize their use in translational research for neocartilage formation.
“…In addition, Muraglia et al also reported that addition of HPL to FBS supplement significantly enhanced the chondrocyte proliferation [42]. Kachroo et al compared the expansion of chondroprogenitor cells isolated from cartilage with HPL and FBS [43]. The authors found that chondroprogenitor cells cultured with HPL have higher proliferation but lower expression of chondrogenic (aggrecan and col II), dedifferentiation (col I) and hypertrophic markers (col X) compared to those expanded with FBS.…”
Section: Human Platelet Lysate As Replacement For Foetal Bovine Serummentioning
Osteoarthritis (OA) is a degenerative joint disease that affects a lot of people worldwide. Current treatment for OA mainly focuses on halting or slowing down the disease progress and to improve the patient’s quality of life and functionality. Autologous chondrocyte implantation (ACI) is a new treatment modality with the potential to promote regeneration of worn cartilage. Traditionally, foetal bovine serum (FBS) is used to expand the chondrocytes. However, the use of FBS is not ideal for the expansion of cells mean for clinical applications as it possesses the risk of animal pathogen transmission and animal protein transfer to host. Human platelet lysate (HPL) appears to be a suitable alternative to FBS as it is rich in biological factors that enhance cell proliferation. Thus far, HPL has been found to be superior in promoting chondrocyte proliferation compared to FBS. However, both HPL and FBS cannot prevent chondrocyte dedifferentiation. Discrepant results have been reported for the maintenance of chondrocyte redifferentiation potential by HPL. These differences are likely due to the diversity in the HPL preparation methods. In the future, more studies on HPL need to be performed to develop a standardized technique which is capable of producing HPL that can maintain the chondrocyte redifferentiation potential reproducibly. This review discusses the in vitro expansion of chondrocytes with FBS and HPL, focusing on its capability to promote the proliferation and maintain the chondrogenic characteristics of chondrocytes.
“…Another standard method to obtain progenitors is based on their migratory potential from cartilage explants in culture 8 , 18 . Both fibronectin adhesion assay derived 19 , 20 and migratory chondroprogenitors 8 , 21 have been likened to MSCs as delineated by the International Society for Cellular Therapy (ISCT) 2006 22 , demonstrating plastic adherence, similar surface marker expression, and trilineage differentiation potential. Extensive work on these progenitors has provided information on their growth characteristics, where fibronectin-derived cells displayed clonal growth and required additional growth factors for expansion, unlike migratory progenitors 23 .…”
Cell-based therapy for articular hyaline cartilage regeneration predominantly involves the use of mesenchymal stem cells and chondrocytes. However, the regenerated repair tissue is suboptimal due to the formation of mixed hyaline and fibrocartilage, resulting in inferior long-term functional outcomes. Current preclinical research points towards the potential use of cartilage-derived chondroprogenitors as a viable option for cartilage healing. Fibronectin adhesion assay-derived chondroprogenitors (FAA-CP) and migratory chondroprogenitors (MCP) exhibit features suitable for neocartilage formation but are isolated using distinct protocols. In order to assess superiority between the two cell groups, this study was the first attempt to compare human FAA-CPs with MCPs in normoxic and hypoxic culture conditions, investigating their growth characteristics, surface marker profile and trilineage potency. Their chondrogenic potential was assessed using mRNA expression for markers of chondrogenesis and hypertrophy, glycosaminoglycan content (GAG), and histological staining. MCPs displayed lower levels of hypertrophy markers (RUNX2 and COL1A1), with normoxia-MCP exhibiting significantly higher levels of chondrogenic markers (Aggrecan and COL2A1/COL1A1 ratio), thus showing superior potential towards cartilage repair. Upon chondrogenic induction, normoxia-MCPs also showed significantly higher levels of GAG/DNA with stronger staining. Focused research using MCPs is required as they can be suitable contenders for the generation of hyaline-like repair tissue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.